ファーマコビジランス・医薬品安全性ソフトウェア市場：製品別、臨床試験別、流通別、エンドユーザー別-2023-2030年の世界予測

ファーマコビジランス・医薬品安全性ソフトウェアの世界市場は、2023年にCAGR14.46%で5億5,210万米ドルが予測され、2030年には14億2,924万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のファーマコビジランス・医薬品安全性ソフトウェア市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：ロシア・ウクライナ紛争、高インフレに関する包括的な理解を提供します。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ファーマコビジランス・医薬品安全性ソフトウェアの世界市場規模および予測は？

2.予測期間中、世界のファーマコビジランス・医薬品安全性ソフトウェア市場を形成するCOVID-19の阻害要因と影響は？

3.ファーマコビジランス・医薬品安全性ソフトウェアの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.ファーマコビジランス・医薬品安全性ソフトウェアの世界市場における競争戦略は？

5.ファーマコビジランス・医薬品安全性ソフトウェアの世界市場における技術動向と規制の枠組みは？

6.ファーマコビジランス・医薬品安全性ソフトウェアの世界市場における主要ベンダーの市場シェアは？

7.ファーマコビジランス・医薬品安全性ソフトウェアの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ADRと薬物毒性の発生率の増加
    • 集約レポートおよび論文の医学文献のレビューに費やす時間を削減する必要性の高まり
    • 高度に規制された医薬品監視スペース
  • 抑制要因
    • ファーマコビジランス・医薬品安全性ソフトウェアの高価な導入
  • 機会
    • ヘルスケア企業別研究開発（R&D）への投資の増加
    • ファーマコビジランス・医薬品安全性ソフトウェアでのAIと機械学習モデルの統合
  • 課題
    • 新興諸国における医薬品副作用（ADR）の認識、トレーニング、過小報告の欠如
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 ファーマコビジランス・医薬品安全性ソフトウェア市場：製品別

• 有害事象報告ソフトウェア
• 医薬品安全性監査ソフトウェア
• 完全に統合されたソフトウェア
• 問題追跡ソフトウェア

第7章 ファーマコビジランス・医薬品安全性ソフトウェア市場臨床試験別

• フェーズI
• フェーズ II
• フェーズⅢ
• フェーズ IV
• 前臨床

第8章 ファーマコビジランス・医薬品安全性ソフトウェア市場配信別

• オンクラウド
• オンプレミス

第9章 ファーマコビジランス・医薬品安全性ソフトウェア市場：エンドユーザー別

• ビジネスプロセスアウトソーシング会社
• 受託調査機関
• 製薬会社およびバイオテクノロジー企業
• 医薬品安全性監視サービスプロバイダー

第10章 南北アメリカのファーマコビジランス・医薬品安全性ソフトウェア市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のファーマコビジランス・医薬品安全性ソフトウェア市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのファーマコビジランス・医薬品安全性ソフトウェア市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2022 VS 2030
• FIGURE 3. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2022 VS 2030 (%)
• FIGURE 6. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
• FIGURE 7. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 8. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET DYNAMICS
• FIGURE 10. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 10. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 16. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 61. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 65. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 134. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. POLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 150. POLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 154. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 192. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 193. PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET LICENSE & PRICING

The Global Pharmacovigilance & Drug Safety Software Market is forecasted to grow significantly, with a projected USD 552.10 million in 2023 at a CAGR of 14.46% and expected to reach a staggering USD 1,429.24 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pharmacovigilance & Drug Safety Software Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pharmacovigilance & Drug Safety Software Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Adverse Event Reporting Software, Drug Safety Audits Software, Fully Integrated Software, and Issue Tracking Software. The Fully Integrated Software commanded largest market share of 29.36% in 2022, followed by Drug Safety Audits Software.

Based on Clinical Trial, market is studied across Phase I, Phase II, Phase III, Phase IV, and Pre-clinical. The Phase I commanded largest market share of 26.06% in 2022, followed by Pre-clinical.

Based on Distribution, market is studied across On-Cloud and On-Premise. The On-Cloud commanded largest market share of 54.51% in 2022, followed by On-Premise.

Based on End User, market is studied across Business Process Outsourcing Firms, Contract Research Organizations, Pharma & Biotech Companies, and Pharmacovigilance Service Providers. The Pharma & Biotech Companies commanded largest market share of 36.29% in 2022, followed by Pharmacovigilance Service Providers.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.00% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pharmacovigilance & Drug Safety Software Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmacovigilance & Drug Safety Software Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmacovigilance & Drug Safety Software Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmacovigilance & Drug Safety Software Market?

4. What is the competitive strategic window for opportunities in the Global Pharmacovigilance & Drug Safety Software Market?

5. What are the technology trends and regulatory frameworks in the Global Pharmacovigilance & Drug Safety Software Market?

6. What is the market share of the leading vendors in the Global Pharmacovigilance & Drug Safety Software Market?

7. What modes and strategic moves are considered suitable for entering the Global Pharmacovigilance & Drug Safety Software Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Pharmacovigilance & Drug Safety Software Market, by Product, 2022 vs 2030
• 4.3. Pharmacovigilance & Drug Safety Software Market, by Clinical Trial, 2022 vs 2030
• 4.4. Pharmacovigilance & Drug Safety Software Market, by Distribution, 2022 vs 2030
• 4.5. Pharmacovigilance & Drug Safety Software Market, by End User, 2022 vs 2030
• 4.6. Pharmacovigilance & Drug Safety Software Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Incidence of ADR and Drug Toxicity
    • 5.1.1.2. Increasing Need to Reduce Time Spent Reviewing Medical Literature for Aggregate Reports and Articles
    • 5.1.1.3. Highly Regulated Pharmacovigilance Space
  • 5.1.2. Restraints
    • 5.1.2.1. Expensive Deployment of Pharmacovigilance & Drug Safety Software
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing Investment in Research and Development (R&D) by Healthcare Companies
    • 5.1.3.2. Integration of AI and Machine Learning Models in Pharmacovigilance & Drug Safety Software
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of Awareness, Training, and Underreporting of Adverse Drug Reactions (ADRs) in Developing Countries
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Pharmacovigilance & Drug Safety Software Market, by Product

• 6.1. Introduction
• 6.2. Adverse Event Reporting Software
• 6.3. Drug Safety Audits Software
• 6.4. Fully Integrated Software
• 6.5. Issue Tracking Software

7. Pharmacovigilance & Drug Safety Software Market, by Clinical Trial

• 7.1. Introduction
• 7.2. Phase I
• 7.3. Phase II
• 7.4. Phase III
• 7.5. Phase IV
• 7.6. Pre-clinical

8. Pharmacovigilance & Drug Safety Software Market, by Distribution

• 8.1. Introduction
• 8.2. On-Cloud
• 8.3. On-Premise

9. Pharmacovigilance & Drug Safety Software Market, by End User

• 9.1. Introduction
• 9.2. Business Process Outsourcing Firms
• 9.3. Contract Research Organizations
• 9.4. Pharma & Biotech Companies
• 9.5. Pharmacovigilance Service Providers

10. Americas Pharmacovigilance & Drug Safety Software Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pharmacovigilance & Drug Safety Software Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

1. 4C Pharma Solutions

2. AB Cube

3. Accenture PLC

4. Advera Health Analytics, Inc.

5. Anju Software, Inc.

6. ArisGlobal LLC

7. Clinevo Technologies Private Limited

8. Cognizant Technology Solutions Corporation

9. Ennov

10. Ergomed PLC

11. Extedo GmbH

12. Indegene Inc.

13. IQVIA Inc.

14. Oracle Corporation

15. Sarjen Systems Private Limited

16. Sparta Systems, Inc.

17. United BioSource LLC

18. Wipro Limited